N/A
N=1,788
Sientra Sponsored Silimed Gel-Filled Breast Implant Core Clinical Study
Breast Augmentation · Breast Reconstruction · Breast Revision
Bottom Line
View on ClinicalTrials.gov: NCT00905645 ↗Enrolled (actual)
1,788
Serious AEs
0.0%
Results posted
Jan 2024
Primary outcome: Primary: Local Complications — 12; 7; 8; 2 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Silimed Gel-Filled Mammary Implant (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Female
- Sponsor
- Tiger Biosciences, LLC.
- Primary completion
- Dec 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Local Complications |
12; 7; 8; 2; 120; 39 | — |
| SECONDARY Satisfaction Determined by Patients |
414; 110; 58; 20; 444; 121 | — |
Summary
Safety and effectiveness of the Silimed Gel-Filled Mammary Implant as indicated for primary augmentation, primary reconstruction, and/or revision of the female breast.
Eligibility Criteria
Inclusion Criteria
Subjects are admitted into the study only if all of the following eligibility is true:
- Female
- Age limitation specific to the indication:
- Primary Augmentation: Must be 18 years or older
- Primary Reconstruction: No age limit
- Revision: If original surgery was primary reconstruction, then no age limit. If original surgery was primary augmentation, then must be 18 years or older.
- Adequate tissue available to cover implant(s)
- Willingness to follow study requirements (informed consent form, follow-up visits)
- Candidate for primary augmentation, primary reconstruction, or revision
Exclusion Criteria
Subjects are not eligible if any of the following criteria exist:
- Advanced fibrocystic disease, considered to be pre-malignant without mastectomy
- Inadequate or unsuitable tissue
- Active infection in the body at the time of surgery
- Pregnant or lactating
- Medical condition that might result in unduly high surgical risk and/or significant postoperative complications, in the judgment of the Investigator
- Use of drugs, including any drug that would interfere with blood clotting, that might result in high risk and/or significant postoperative complications
- Demonstrated psychological characteristics that are unrealistic or unreasonable given the risks involved with the surgical procedure
- Determination by physical examination that the subject does have any connective tissue/autoimmune disorder
- Existing carcinoma of the breast without accompanying mastectomy
- MRI scan is prohibited because of implanted metal device, claustrophobia, or other condition.
Data sourced from ClinicalTrials.gov (NCT00905645). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.